Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
Filing tables
Filing exhibits
- 10-K Annual report
- 4 Description of Capital Stock
- 10.17 Assignment and Assumption Agreement Between Allarity Therapeutics, Inc. and Allarity A/s
- 10.18 Exclusive License Agreement with Oncoheroes Bioscience, Inc. Dated January 2, 2022 (Stenoparib)
- 10.19 Exclusive License Agreement with Oncoheroes Bioscience, Inc. Dated January 2, 2022 (Dovitnib)
- 10.20 Amended and Restated License Agreement Among Allarity Therapeutics Europe Aps, Liplasome Pharma Aps, and Chosa Aps Dated March 28, 2022
- 10.21 Support Agreement Between Allarity Therapeutics A/s and Liplasome Pharma Aps, Dated March 28, 2022
- 21.1 Subsidiaries of the Registrant
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- Download Excel data file
- View Excel data file
ALLR similar filings
Filing view
External links